Ethical considerations of recruiting migrant workers for clinical trials

被引:3
|
作者
Amin, Bushra Zafreen [1 ]
机构
[1] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
关键词
Research Ethics; Informed Consent; Research on Special Populations; Coercion; Clinical trials; PATERNALISM;
D O I
10.1136/medethics-2020-106767
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
Migrant workers in dormitories are an attractive source of clinical trial participants. However, they are a vulnerable population that has been disproportionately affected by the COVID-19 pandemic. Guidelines on recruiting vulnerable populations (such as prisoners, children or the mentally impaired) for clinical trials have long been established, but ethical considerations for migrant workers have been neglected. This article aims to highlight and explain what researchers recruiting migrant workers must be cognizant of, and offers recommendations to address potential concerns. The considerations raised in this article include: three types of illiteracy, power dynamics, the risks associated with communal living and potential benefits to the migrant workers as well as researchers.
引用
收藏
页码:434 / 436
页数:3
相关论文
共 50 条
  • [31] Ethical considerations in clinical neuroscience - Current concepts in neuroclinical trials
    Alves, WA
    Macciocchi, SN
    STROKE, 1996, 27 (10) : 1903 - 1909
  • [32] Ethical Considerations for the Participation of Children of Minor Parents in Clinical Trials
    Mary A. Ott
    Francis P. Crawley
    Xavier Sáez-Llorens
    Seth Owusu-Agyei
    David Neubauer
    Gary Dubin
    Tatjana Poplazarova
    Norman Begg
    Susan L. Rosenthal
    Pediatric Drugs, 2018, 20 : 215 - 222
  • [33] Inclusion of pregnant populations in clinical trials in China: the ethical considerations
    Chen, Xiaoyan
    Shi, Huifeng
    Wilkinson, Barbara
    Zhu, Yuanfang
    LANCET RHEUMATOLOGY, 2024, 6 (11): : e746 - e747
  • [34] Ethical Considerations for the Participation of Children of Minor Parents in Clinical Trials
    Ott, Mary A.
    Crawley, Francis P.
    Saez-Llorens, Xavier
    Owusu-Agyei, Seth
    Neubauer, David
    Dubin, Gary
    Poplazarova, Tatjana
    Begg, Norman
    Rosenthal, Susan L.
    PEDIATRIC DRUGS, 2018, 20 (03) : 215 - 222
  • [35] ETHICAL CONSIDERATIONS IN PHASE-I CLINICAL-TRIALS
    SASS, HM
    ONKOLOGIE, 1990, 13 (02): : 85 - 88
  • [36] Ethical considerations in placebo-controlled randomised clinical trials
    Kaufman, Kenneth R.
    BJPSYCH OPEN, 2015, 1 (01): : E3 - E4
  • [37] Ethical Considerations in the Design and Conduct of Clinical Trials of Artificial Intelligence
    Youssef, Alaa
    Nichol, Ariadne A.
    Martinez-Martin, Nicole
    Larson, David B.
    Abramoff, Michael
    Wolf, Risa M.
    Char, Danton
    JAMA NETWORK OPEN, 2024, 7 (09)
  • [38] Ethical considerations in industry-sponsored Multiregional Clinical Trials
    Ibia, Ekopimo
    Binkowitz, Bruce
    Saillot, Jean-Louis
    Talerico, Steven
    Koerner, Chin
    Ferreira, Irene
    Agarwal, Anupam
    Metz, Craig
    Maman, Marianne
    PHARMACEUTICAL STATISTICS, 2010, 9 (03) : 230 - 241
  • [39] Ethical considerations in neuroclinical trials
    Macciocchi, SN
    Alves, WA
    NEUROSURGICAL REVIEW, 1997, 20 (03) : 161 - 170
  • [40] Ethical considerations in neuroclinical trials
    Stephen N. Macciocchi
    Wayne A. Alves
    Neurosurgical Review, 1997, 20 : 161 - 170